Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Dr Galbraith wrote to the DHSS recommending the withdrawal of US blood products due to the risk of AIDS transmission.

Published on: 24 September, 2024

The Council of Europe's Committee of Ministers' resolution recommending "all necessary steps and measures with respect to" AIDS be taken was adopted.

Published on: 22 July, 2024

The publication of the leaflet "AIDS and how it affects blood donors" was announced.

Published on: 22 July, 2024

The Expert Advisory Group on AIDS had its first meeting.

Published on: 22 July, 2024

The second leaflet, titled "AIDS; important new advice for blood donors", was made available to Regional Transfusion Centres.

Published on: 22 July, 2024

It was discovered that heat will inactivate hepatitis virus (in albumin).

Published on: 22 July, 2024

Cutter conducted experiments with heat treatment which showed Factor 9 activity could be preserved.

Published on: 22 July, 2024

Research was underway at PFC to find a way of physically removing Hepatitis B.

Published on: 22 July, 2024

Dr Harvey Alter called for viral inactivation. Calls were made by others too.

Published on: 22 July, 2024

Cutter created a task force to try to solve "the hepatitis problem".

Published on: 22 July, 2024

Behringwerke conducted experiments in heat treatment and began clinical trials.

Published on: 22 July, 2024

Hyland experimented with dry heat approach.

Published on: 22 July, 2024

Behringwerke presented its heat-treated process at the Bonn Conference.

Published on: 22 July, 2024

PFC started performing experiments on pasteurisation.

Published on: 22 July, 2024

Alpha assessed it had the "nucleus of a process that needs about three or four months' work", and applied for a FDA licence for heat-treated product in January 1983.

Published on: 22 July, 2024

BPL started development work on a heat-treated 'Hepatitis-Safe' Factor 8 product.

Published on: 22 July, 2024

FDA licensed Hyland's dry heat-treated product.

Published on: 22 July, 2024

FDA licensed Armour's heat-treated product, followed by Alpha's and Cutter's products in February 1984.

Published on: 22 July, 2024

Haemophilia centres at Sheffield, St Thomas', Middlesex and Margate started to use heat-treated concentrates.

Published on: 22 July, 2024

BPL started intensive development of what would become 8Y.

Published on: 22 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 1996
  • Page 1997
  • Page 1998
  • Page 1999
  • Current page 2000
  • Page 2001
  • Page 2002
  • Page 2003
  • Page 2004
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.